Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

PI3K/Akt responses to oxytocin stimulation in Caco2BB gut cells.

Klein BY, Tamir H, Welch MG.

J Cell Biochem. 2011 Nov;112(11):3216-26. doi: 10.1002/jcb.23243.

PMID:
21732407
2.

Oxytocin modulates mTORC1 pathway in the gut.

Klein BY, Tamir H, Hirschberg DL, Glickstein SB, Welch MG.

Biochem Biophys Res Commun. 2013 Mar 15;432(3):466-71. doi: 10.1016/j.bbrc.2013.01.121. Epub 2013 Feb 11.

3.

The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.

Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):421-9. doi: 10.1167/iovs.09-3974. Epub 2009 Aug 6.

PMID:
19661225
4.

Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.

Cassoni P, Fulcheri E, Carcangiu ML, Stella A, Deaglio S, Bussolati G.

J Pathol. 2000 Mar;190(4):470-7.

PMID:
10699997
5.

Oxytocin modulates markers of the unfolded protein response in Caco2BB gut cells.

Klein BY, Tamir H, Hirschberg DL, Glickstein SB, Ludwig RJ, Welch MG.

Cell Stress Chaperones. 2014 Jul;19(4):465-77. doi: 10.1007/s12192-013-0473-4. Epub 2013 Nov 6.

6.

Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.

Hua K, Feng W, Cao Q, Zhou X, Lu X, Feng Y.

Int J Oncol. 2008 Nov;33(5):959-67.

PMID:
18949358
7.

Molecular cloning and functional characterization of the oxytocin receptor from a rat pancreatic cell line (RINm5F).

Jeng YJ, Lolait SJ, Strakova Z, Chen C, Copland JA, Mellman D, Hellmich MR, Soloff MS.

Neuropeptides. 1996 Dec;30(6):557-65.

PMID:
9004255
8.

Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.

Péqueux C, Keegan BP, Hagelstein MT, Geenen V, Legros JJ, North WG.

Endocr Relat Cancer. 2004 Dec;11(4):871-85.

9.

Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.

Marzec M, Kasprzycka M, Liu X, El-Salem M, Halasa K, Raghunath PN, Bucki R, Wlodarski P, Wasik MA.

Oncogene. 2007 Aug 16;26(38):5606-14. Epub 2007 Mar 12.

PMID:
17353907
10.

2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.

Li CM, Narayanan R, Lu Y, Hurh E, Coss CC, Barrett CM, Miller DD, Dalton JT.

Int J Oncol. 2010 Oct;37(4):1023-30.

PMID:
20811725
11.

Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.

Generali D, Fox SB, Brizzi MP, Allevi G, Bonardi S, Aguggini S, Milani M, Bersiga A, Campo L, Dionisio R, Vergoni F, Giardini R, Dogliotti L, Bottini A, Harris AL, Berruti A.

Clin Cancer Res. 2008 May 1;14(9):2673-80. doi: 10.1158/1078-0432.CCR-07-1046.

12.

ERK2 mediates oxytocin-stimulated PGE2 synthesis.

Strakova Z, Copland JA, Lolait SJ, Soloff MS.

Am J Physiol. 1998 Apr;274(4 Pt 1):E634-41.

13.

Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.

Svejda B, Kidd M, Kazberouk A, Lawrence B, Pfragner R, Modlin IM.

Cancer. 2011 Sep 15;117(18):4141-54. doi: 10.1002/cncr.26011. Epub 2011 Mar 8.

14.

[The regulation of human myometrial oxytocin receptor expression by oxytocin].

Adachi S, Oku M.

Nihon Sanka Fujinka Gakkai Zasshi. 1995 Feb;47(2):87-93. Japanese.

PMID:
7706861
15.

Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling.

Péqueux C, Breton C, Hendrick JC, Hagelstein MT, Martens H, Winkler R, Geenen V, Legros JJ.

Cancer Res. 2002 Aug 15;62(16):4623-9.

16.
17.

Combined inhibition of PI3K and mTOR exerts synergistic antiproliferative effect, but diminishes differentiative properties of rapamycin in acute myeloid leukemia cells.

Mise J, Dembitz V, Banfic H, Visnjic D.

Pathol Oncol Res. 2011 Sep;17(3):645-56. doi: 10.1007/s12253-011-9365-z. Epub 2011 Feb 19.

PMID:
21336564
18.

IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.

Bibollet-Bahena O, Almazan G.

J Neurochem. 2009 Jun;109(5):1440-51. doi: 10.1111/j.1471-4159.2009.06071.x. Epub 2009 Mar 28.

19.

Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.

Kim JH, Kang TH, Noh KH, Kim SH, Lee YH, Kim KW, Bae HC, Ahn YH, Choi EY, Kim JS, Lee KM, Kim TW.

Immunol Lett. 2010 Nov 30;134(1):47-54. doi: 10.1016/j.imlet.2010.08.008. Epub 2010 Aug 19.

PMID:
20727912
20.

Oxytocin opposes effects of bacterial endotoxin on ER-stress signaling in Caco2BB gut cells.

Klein BY, Tamir H, Hirschberg DL, Ludwig RJ, Glickstein SB, Myers MM, Welch MG.

Biochim Biophys Acta. 2016 Feb;1860(2):402-11. doi: 10.1016/j.bbagen.2015.10.025. Epub 2015 Oct 28.

PMID:
26520666

Supplemental Content

Support Center